BioCorRx (BICX) Revenue (2011 - 2026)
BioCorRx recorded quarterly Revenue of $214539.0 in Q1 2026, down 42.93% quarter-over-quarter from $375929.0 in Q4 2025, and up 59.04% year-over-year from $134899.0 in Q1 2025.
BioCorRx's Revenue history runs 16 years deep, the most recent figure standing at $214539.0 for Q1 2026.
- In Q1 2026, Revenue rose 59.04% year-over-year to $214539.0; the TTM figure through Mar 2026 stood at $1.2 million (up 756.47% YoY), while the FY2025 annual figure was $797244.0, up 10301.1% from the prior year.
- Revenue came in at $214539.0 for Q1 2026 at BioCorRx, down from $375929.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $421314.0 in Q3 2025 to a low of $3620.0 in Q1 2024.
- A 5-year average of $109039.0 and a median of $40442.0 in 2023 frame the typical range for Revenue.
- Across the five-year window, Revenue sank 91.05% in 2024 and jumped 4306.38% in 2025, its largest moves.
- BioCorRx's Revenue stood at $82880.0 in 2022, then tumbled by 77.15% to $18938.0 in 2023, then plunged by 78.64% to $4045.0 in 2024, then jumped by 9193.67% to $375929.0 in 2025, then plunged by 42.93% to $214539.0 in 2026.
- According to Business Quant data, Revenue over the past three periods registered $214539.0, $375929.0, and $421314.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | 19.11 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | 5.37 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | 3.42 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | 1.59 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | 1.39 Bn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | 4.50 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | 22,847.38 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | 657.51 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | 1.42 Bn |
| 10 | BioCorRx | - | - | 189,355.00 | 214,539.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 214,539.00 |
| Dec 31, 2025 | 375,929.00 |
| Sep 30, 2025 | 635,224.00 |
| Jun 30, 2025 | 178,238.00 |
| Mar 31, 2025 | 134,899.00 |
| Jun 30, 2024 | 4,045.00 |
| Mar 31, 2024 | 3,620.00 |
| Dec 31, 2023 | 18,938.00 |
| Sep 30, 2023 | 10,145.00 |
| Jun 30, 2023 | 19,635.00 |
| Mar 31, 2023 | 40,442.00 |
| Dec 31, 2022 | 82,880.00 |
| Sep 30, 2022 | 94,441.00 |
| Jun 30, 2022 | 16,002.00 |
| Mar 31, 2022 | 20,518.00 |
| Dec 31, 2021 | 13,613.00 |
| Sep 30, 2021 | 8,817.00 |
| Jun 30, 2021 | 15,718.00 |
| Mar 31, 2021 | 10,124.00 |
| Dec 31, 2020 | 22,222.00 |
| Sep 30, 2020 | 29,809.00 |
| Jun 30, 2020 | 33,695.00 |
| Mar 31, 2020 | 36,895.00 |
| Dec 31, 2019 | 62,448.00 |
| Sep 30, 2019 | 46,561.00 |
| Jun 30, 2019 | 65,976.00 |
| Mar 31, 2019 | 65,274.00 |
| Dec 31, 2018 | 51,674.00 |
| Sep 30, 2018 | 78,584.00 |
| Jun 30, 2018 | 98,674.00 |
| Mar 31, 2018 | 147,724.00 |
| Dec 31, 2017 | 164,907.00 |
| Sep 30, 2017 | 147,593.00 |
| Jun 30, 2017 | 210,544.00 |
| Mar 31, 2017 | 134,227.00 |
| Dec 31, 2016 | 115,849.00 |
| Sep 30, 2016 | 167,598.00 |
| Jun 30, 2016 | 187,912.00 |
| Mar 31, 2016 | 230,413.00 |
| Dec 31, 2015 | 73,295.00 |
| Sep 30, 2015 | 118,192.00 |
| Jun 30, 2015 | 457,780.00 |
| Mar 31, 2015 | 275,465.00 |
| Dec 31, 2014 | 368,044.00 |
| Sep 30, 2014 | 434,041.00 |
| Jun 30, 2014 | 238,008.00 |
| Mar 31, 2014 | 130,829.00 |
| Dec 31, 2013 | -449,608.00 |
| Sep 30, 2013 | 277,410.00 |
| Mar 31, 2013 | 387,209.00 |
| Dec 31, 2012 | 364,096.00 |
| Sep 30, 2012 | 63,973.00 |
| Jun 30, 2012 | 179,209.00 |
| Mar 31, 2012 | 260,883.00 |
| Dec 31, 2011 | 93,573.00 |
| Sep 30, 2011 | 344,309.00 |
| Jun 30, 2011 | 305,230.00 |
| Mar 31, 2011 | 28,650.00 |